Shailendra Menjoge

3.4k total citations · 1 hit paper
26 papers, 2.5k citations indexed

About

Shailendra Menjoge is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Statistics and Probability. According to data from OpenAlex, Shailendra Menjoge has authored 26 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 12 papers in Physiology and 8 papers in Statistics and Probability. Recurrent topics in Shailendra Menjoge's work include Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers), Asthma and respiratory diseases (12 papers) and Respiratory Support and Mechanisms (12 papers). Shailendra Menjoge is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers), Asthma and respiratory diseases (12 papers) and Respiratory Support and Mechanisms (12 papers). Shailendra Menjoge collaborates with scholars based in United States, United Kingdom and Germany. Shailendra Menjoge's co-authors include Donald P. Tashkin, Steven Kesten, Stephen Senn, Marc Decramer, Bartolomé R. Celli, D Burkhart, Theodore J. Witek, Charles W. Serby, Mitchell Friedman and Dick D. Briggs and has published in prestigious journals such as New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Shailendra Menjoge

25 papers receiving 2.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease

2008 1.6k citations Donald P. Tashkin, Bartolomé R. Celli et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shailendra Menjoge United States	15	2.2k	1.5k	141	110	105	26	2.5k
Donald Banerji United States	29	3.8k 1.7×	3.2k 2.1×	10 0.1×	65 0.6×	119 1.1×	155	4.0k
Sally Lettis United Kingdom	17	1.4k 0.7×	1.2k 0.8×	18 0.1×	129 1.2×	140 1.3×	41	1.9k
Katharine Knobil United States	19	2.4k 1.1×	1.7k 1.1×	5 0.0×	157 1.4×	109 1.0×	26	2.8k
Hungta Chen United States	21	1.1k 0.5×	896 0.6×	8 0.1×	147 1.3×	27 0.3×	106	2.1k
Philippa Shirtcliffe New Zealand	17	659 0.3×	414 0.3×	4 0.0×	107 1.0×	53 0.5×	20	1.0k
Flory L. Nkoy United States	20	230 0.1×	247 0.2×	13 0.1×	101 0.9×	38 0.4×	49	913
Y. K. Loke United Kingdom	12	267 0.1×	211 0.1×	46 0.3×	192 1.7×	10 0.1×	26	1.1k
Craig Plauschinat United States	18	330 0.2×	234 0.2×	8 0.1×	92 0.8×	19 0.2×	29	1.3k
Hanne Madsen Denmark	16	273 0.1×	199 0.1×	4 0.0×	47 0.4×	30 0.3×	35	761
Laurence B. Gardner United States	12	244 0.1×	158 0.1×	8 0.1×	92 0.8×	32 0.3×	32	893

Countries citing papers authored by Shailendra Menjoge

Since Specialization

Citations

This map shows the geographic impact of Shailendra Menjoge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shailendra Menjoge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shailendra Menjoge more than expected).

Fields of papers citing papers by Shailendra Menjoge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shailendra Menjoge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shailendra Menjoge. The network helps show where Shailendra Menjoge may publish in the future.

Co-authorship network of co-authors of Shailendra Menjoge

This figure shows the co-authorship network connecting the top 25 collaborators of Shailendra Menjoge. A scholar is included among the top collaborators of Shailendra Menjoge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shailendra Menjoge. Shailendra Menjoge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tabberer, Maggie, Victoria S. Benson, Heather L. Gelhorn, et al.. (2017). The COPD Biomarkers Qualification Consortium Database: Baseline Characteristics of the St George’s Respiratory Questionnaire Dataset. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 4(2). 108–119. 9 indexed citations

Jones, Paul, Heather L. Gelhorn, Niklas Karlsson, et al.. (2017). Baseline Severity as Predictor of Change in St George’s Respiratory Questionnaire Scores in Trials of Long-acting Bronchodilators with COPD Patients. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 4(2). 128–136. 3 indexed citations

Jones, Paul, Heather L. Gelhorn, Hilary Wilson, et al.. (2017). Socioeconomic Status as a Determinant of Health Status Treatment Response in COPD Trials. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 4(2). 146–154. 10 indexed citations

Müllerová, Hana, Heather L. Gelhorn, Hilary Wilson, et al.. (2015). Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database. PA3017–PA3017. 1 indexed citations

Girman, Cynthia J., Ekopimo Ibia, Shailendra Menjoge, et al.. (2011). Impact of Different Regulatory Requirements for Trial Endpoints in Multiregional Clinical Trials. Drug Information Journal. 45(5). 587–594. 9 indexed citations

Gallo, Paul, Joshua Chen, Hui Quan, et al.. (2011). Consistency of Treatment Effect across Regions in Multiregional Clinical Trials, Part 2: Monitoring, Reporting, and Interpretation. Drug Information Journal. 45(5). 603–608. 13 indexed citations

Chen, Joshua, Hui Quan, Bruce Binkowitz, et al.. (2010). Assessing consistent treatment effect in a multi‐regional clinical trial: a systematic review. Pharmaceutical Statistics. 9(3). 242–253. 37 indexed citations

Halpin, David, Shailendra Menjoge, & K. Viel. (2009). Patient-level pooled analysis of the effect of tiotropium on COPD exacerbations and related hospitalisations. Primary Care Respiratory Journal. 18(2). 106–113. 17 indexed citations

Tashkin, Donald P., Bartolomé R. Celli, Stephen Senn, et al.. (2008). A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease. New England Journal of Medicine. 359(15). 1543–1554. 1571 indexed citations breakdown →

10.

Hodder, Richard V., Steven Kesten, Shailendra Menjoge, & K. Viel. (2007). Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.. PubMed. 2(2). 157–67. 24 indexed citations

11.

Adams, Sylvia, Antonio Anzueto, Dick D. Briggs, Shailendra Menjoge, & Steven Kesten. (2006). Tiotropium in COPD patients not previously receiving maintenance respiratory medications. Respiratory Medicine. 100(9). 1495–1503. 21 indexed citations

12.

Menjoge, Shailendra. (2003). On estimation of frequency data with censored observations. Pharmaceutical Statistics. 2(3). 191–197. 3 indexed citations

13.

Littner, Michael R., Jonathan Ilowite, Donald P. Tashkin, et al.. (2000). Long-Acting Bronchodilation with Once-Daily Dosing of Tiotropium (Spiriva) in Stable Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 161(4). 1136–1142. 162 indexed citations

14.

Casaburi, Richard, Dick D. Briggs, James F. Donohue, et al.. (2000). The Spirometric Efficacy of Once-Daily Dosing With Tiotropium in Stable COPD. CHEST Journal. 118(5). 1294–1302. 153 indexed citations

15.

Reisner, Colin, et al.. (1999). Analysis of Inhaled Corticosteroid and Oral Theophylline Use Among Patients With Stable COPD from 1987 to 1995. CHEST Journal. 115(3). 703–707. 47 indexed citations

16.

Friedman, Mitchell, Charles W. Serby, Shailendra Menjoge, et al.. (1999). Pharmacoeconomic Evaluation of a Combination of Ipratropium Plus Albuterol Compared With Ipratropium Alone and Albuterol Alone in COPD. CHEST Journal. 115(3). 635–641. 126 indexed citations

17.

Dorinsky, Paul, Colin Reisner, Gary T. Ferguson, et al.. (1999). The Combination of Ipratropium and Albuterol Optimizes Pulmonary Function Reversibility Testing in Patients With COPD. CHEST Journal. 115(4). 966–971. 69 indexed citations

18.

Karpel, Jill P., Peter J. Spiro, Thomas K. Aldrich, et al.. (1996). A Comparison of Ipratropium and Albuterol vs Albuterol Alone for the Treatment of Acute Asthma. CHEST Journal. 110(3). 611–616. 56 indexed citations

19.

Cohen, Jonathan P. & Shailendra Menjoge. (1988). One-sample run tests of symmetry. Journal of Statistical Planning and Inference. 18(1). 93–100. 11 indexed citations

20.

Menjoge, Shailendra. (1984). On double k-class estimators of coefficients in linear regression. Economics Letters. 15(3-4). 295–300. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact